Dendritic cells targeting the Lactobacillus plantarum NC8 strain with a surface-displayed single-chain variable fragment of CD11c induce an antigen-specific protective cellular immune response.
Influenza A (H1N1) is an acute, highly contagious respiratory virus. The use of lactic acid bacteria (LAB) to deliver mucosal vaccines against influenza virus infection is a research hotspot. In this study, two recombinant Lactobacillus plantarum (L. plantarum) strains expressing HA alone or coexpressing aCD11c-HA, to target HA protein to dendritic cells (DCs) by fusion to an anti-CD11c single-chain antibody (aCD11c), were constructed. The activation of bone marrow dendritic cells (BMDCs) by recombinant strains and the interaction of activated BMDCs and sorted CD4+ or CD8+ T cells were evaluated through flow cytometry (FCM) in vitro, and cellular supernatants were assessed using an enzyme-linked immunosorbent assay (ELISA) kit. The results demonstrated that compared to the HA strain, the aCD11c-HA strain significantly increased the activation of BMDCs and increased the production of CD4+ IFN-γ+ T cells, CD8+IFN-γ+ T cells and IFN-γ in the cell culture supernatant in vitro Consistent with these results, the aCD11c-HA strain clearly increased the activation and maturation of DCs, the HA-specific responses of CD4+IFN-γ+ T cells, CD8+IFN-γ+ T cells, and CD8+CD107a+ T cells and the proliferation of T cells in the spleen, finally increasing the levels of specific antibodies and neutralizing antibodies in mice. In addition, the protection of immunized mice was observed after viral infection, as evidenced by improved weight loss, survival and lung pathology. The adoptive transfer of CD8+ T cells from the aCD11c-HA mice to NOD/Lt-SCID mice resulted in a certain level of protection after influenza virus infection, highlighting the efficacy of the aCD11c targeting strategy.